<p>A conversation with Jason Hardaway of Ciita Inc. on the primary drivers of the recent growth in the 340B program and the impact to manufacturers. </p>

A conversation with Jason Hardaway of Ciita Inc. on the primary drivers of the recent growth in the 340B program and the impact to manufacturers.

<p>A conversation with Jason Hardaway of Ciita Inc. on the primary drivers of the recent growth in the 340B program and the impact to manufacturers.&nbsp;</p>

The Challenges of the 340B Program

The pharmaceutical industry’s gold standard provider of market access insights. 

For clients of HMP Market Access Insights, Insights to Access features interviews with experts in the oncology management space.

Business

Medicine

Health & Fitness

Education

Management

The pharmaceutical industry’s gold standard provider of market access insights. For clients of HMP Market Access Insights, Insights to Access features interviews with experts in the oncology management space.

Share The Challenges of the 340B Program

Sign up to save your podcasts

The Challenges of the 340B Program

The Challenges of the 340B Program